SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-22-042035
Filing Date
2022-02-14
Accepted
2022-02-14 16:53:11
Documents
2
Group Members
THIRD ROCK VENTURES GP IV, L.P.TRV GP IV, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d295105dsc13ga.htm SC 13G/A 88436
2 EX-99.1 d295105dex991.htm EX-99.1 9103
  Complete submission text file 0001193125-22-042035.txt   99118
Mailing Address 29 NEWBURY STREET, 3RD FLOOR BOSTON MA 02116
Business Address 29 NEWBURY STREET, 3RD FLOOR BOSTON MA 02116 617-585-2000
Third Rock Ventures IV, L.P. (Filed by) CIK: 0001688327 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Magenta Therapeutics, Inc. (Subject) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90538 | Film No.: 22633903
SIC: 2834 Pharmaceutical Preparations